Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes: systematic review and meta-analysis

Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes: systematic review and meta-analysis

Objective To examine cardiovascular and kidney benefits and harms of sodium-glucose co-transporter-2 (SGLT-2) inhibitors stratified by risk in adults with chronic kidney disease regardless of diabetes status.Design Systematic review and meta-analysis.Data sources Ovid Medline, Embase, and Cochrane C...

Full description

Saved in:
Bibliographic Details
Main Authors: Gordon Guyatt, Arnav Agarwal, Thomas Agoritsas, Haoming Tian, Sheyu Li, Chang Xu, Ping Fu, Qingyang Shi, Xiaoxi Zeng, Per Olav Vandvik, Xinyu Zou, Yunhe Mao, Qinbo Yang, Xianghang Luo, Belen Ponte
Format: Article
Language:English
Published: BMJ Publishing Group 2024-08-01
Series:BMJ Medicine
Online Access:https://bmjmedicine.bmj.com/content/3/1/e001009.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items